These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H. J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753 [Abstract] [Full Text] [Related]
24. Exercise-induced ventricular arrhythmias in congestive heart failure and role of ACE inhibitors. Hasija PK, Karloopia SD, Shahi BN, Chauhan SS. J Assoc Physicians India; 1998 Feb; 46(2):189-93. PubMed ID: 11273109 [Abstract] [Full Text] [Related]
25. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure. Dékány M, Bányai F, Antalóczy Z. Acta Physiol Hung; 1988 Feb; 72 Suppl():93-110. PubMed ID: 3075406 [Abstract] [Full Text] [Related]
26. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
33. Lisinopril: a new ACE inhibitor for the treatment of hypertension and congestive heart failure. Chodoff L. Mt Sinai J Med; 1990 May; 57(3):169-71. PubMed ID: 2164644 [No Abstract] [Full Text] [Related]
34. Lisinopril versus placebo in older congestive heart failure patients. Lewis GR. Am J Med; 1988 Sep 23; 85(3B):48-54. PubMed ID: 2844088 [Abstract] [Full Text] [Related]
35. Safety and efficacy of lisinopril in elderly patients with mild to moderate hypertension. Marlier R, Vandepapelière P, De Vriese G. J Hum Hypertens; 1989 Jun 23; 3 Suppl 1():163-7. PubMed ID: 2550639 [Abstract] [Full Text] [Related]
36. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ. Lancet; 2000 Aug 19; 356(9230):615-20. PubMed ID: 10968433 [Abstract] [Full Text] [Related]
37. Comparison of treatment with lisinopril versus enalapril for congestive heart failure. Zannad F, van den Broek SA, Bory M. Am J Cardiol; 1992 Oct 08; 70(10):78C-83C. PubMed ID: 1329478 [Abstract] [Full Text] [Related]
39. Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Lancaster SG, Todd PA. Drugs; 1988 Jun 08; 35(6):646-69. PubMed ID: 2844497 [Abstract] [Full Text] [Related]